Family Medicine Initiative

APRIL 9, 2024

Demand for new obesity medications like semaglutide (GLP-1 analogs) is high, but availability is low. Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? mg or placebo in 2019. So, which patients should get them first? semaglutide 1.0

Diabetes 130

Diabetes Patients Medical Family Medicine 130

Annals of Family Medicine

NOVEMBER 20, 2024

Health insurance instability may be particularly challenging for patients with diabetes who need regular chronic care management to reduce the risk of diabetes complications. 46,844 patients were diagnosed with diabetes during study period. 46,844 patients were diagnosed with diabetes during study period.

Patient-Centered 130

Patient-Centered Insurance Diabetes Community 130

Physician's Weekly

JUNE 23, 2025

Authors of an abstract presented at the American Diabetes Association’s 85th Scientific Sessions called for a holistic, chronic treatment model to support children and young adults with obesity. Guidelines recommend treating obesity with medications and lifestyle changes.” The data spanned from January 2019 to March 2024.

Holistic Care 52

Holistic Care Complication Asthma Electronics 52

Medical Xpress

JUNE 8, 2025

The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form. Learn more Your name Note Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipients address will be used for any other purpose.

IT 53

IT Management Vaccination Medical 53